In the latest edition of the DECODER series, healthcare research analysts Myles Minter, Ph.D., partner, and Sami Corwin, Ph.D., examine emerging gene-editing technologies and their potential to improve treatment across a range of diseases.
The report presents how these technologies work, how different gene editing technologies compare, the key risks associated with each developing therapy, and strategies to address those challenges. It also reviews the most relevant clinical data available today.
Looking ahead, our analysts believe continued positive clinical data will serve as a catalyst for this subsector and support the generation of viable therapies for patients with severe unmet needs.
For more information on William Blair’s biotechnology research, contact us or your William Blair representative.